Oxy-Med, Oxymetholone, 50 mg, 120 Tabs

Oxymetholone 50 mg tablets by Bioniche Pharma are a highly potent oral anabolic formulation engineered for rapid tissue-building capacity. By driving cellular nitrogen conservation and accelerating protein synthesis, Bioniche Pharma Oxymetholone reverses severe hypercatabolic depletion when paired with balanced caloric and nutritional intake.

CLINICAL PHARMACOLOGY & DYNAMICS

Oxymetholone in Bioniche Pharma Oxymetholone is a modified derivative of dihydrotestosterone that binds directly to nuclear androgen receptors to stimulate tissue-building metabolic pathways. While designed to display a high anabolic-to-androgenic clinical ratio, androgenic activity cannot be fully eliminated, meaning mild-to-moderate androgenic features may arise based on dose and individual sensitivity during Bioniche Pharma Oxymetholone therapy.

INDICATIONS & CLINICAL USE

Indicated for short-term supportive therapy to counter catabolic wasting and rebuild lean tissue during rehabilitation from severe medical conditions using Bioniche Pharma formulations:

• Post-surgical recovery following major operative interventions utilizing Bioniche Pharma anabolic support.
• Convalescence from extensive thermal burns, severe skeletal fractures, or traumatic physical injury under clinical direction.
• Management of involuntary cachectic weight loss, severe chronic infections, and debilitating wasting syndromes with Bioniche Pharma treatment protocols.

CONTRAINDICATIONS

• Male patients presenting with diagnosed or suspected prostate carcinoma or male breast cancer.
• Female breast carcinoma complicated by hypercalcemia, as exogenous androgens can accelerate osteolytic bone breakdown.
• Pregnancy, planned pregnancy, and lactation due to high risks of female fetal masculinization and developmental toxicity.
• Known hypersensitivity or allergic response to Oxymetholone or inactive compounding excipients in Bioniche Pharma tablets.

PRECAUTIONS & FLUID BALANCE

• Fluid & Electrolyte Retention: Bioniche Pharma Oxymetholone therapy can induce significant sodium, chloride, and water conservation, resulting in peripheral edema. Close clinical monitoring is required for patients with underlying cardiovascular disease, hypertension, or renal impairment.
• Hepatic Surveillance: As a $17\alpha$-alkylated oral compound, regular laboratory assessment of liver transaminases (AST/ALT), hepatic function, and serum lipid fractions is essential during Bioniche Pharma Oxymetholone administration.

DRUG INTERACTIONS

• Oral Anticoagulants: Anabolic-androgenic agents enhance sensitivity to coumarin-derived blood thinners. Patients co-administered Bioniche Pharma Oxymetholone with oral anticoagulants require frequent prothrombin time (PT/INR) testing and potential anticoagulant dose reductions to avoid bleeding risks.

DOSAGE & ADMINISTRATION

Dosing protocols for Oxymetholone 50 mg by Bioniche Pharma should be individually calculated and managed under direct medical direction, taking into consideration clinical goals, course duration, and diagnostic laboratory panels.

STORAGE & HANDLING

Store Bioniche Pharma Oxymetholone in a dry, cool location protected from direct light exposure and excess atmospheric moisture. Keep strictly out of the reach and sight of children.